157 related articles for article (PubMed ID: 31992566)
1. Inhibition of the SRC Kinase HCK Impairs STAT3-Dependent Gastric Tumor Growth in Mice.
Poh AR; Dwyer AR; Eissmann MF; Chand AL; Baloyan D; Boon L; Murrey MW; Whitehead L; O'Brien M; Lowell CA; Putoczki TL; Pixley FJ; O'Donoghue RJJ; Ernst M
Cancer Immunol Res; 2020 Apr; 8(4):428-435. PubMed ID: 31992566
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Hematopoietic Cell Kinase Activity Suppresses Myeloid Cell-Mediated Colon Cancer Progression.
Poh AR; Love CG; Masson F; Preaudet A; Tsui C; Whitehead L; Monard S; Khakham Y; Burstroem L; Lessene G; Sieber O; Lowell C; Putoczki TL; O'Donoghue RJJ; Ernst M
Cancer Cell; 2017 Apr; 31(4):563-575.e5. PubMed ID: 28399411
[TBL] [Abstract][Full Text] [Related]
3. Activation of STAT3 by the Src family kinase Hck requires a functional SH3 domain.
Schreiner SJ; Schiavone AP; Smithgall TE
J Biol Chem; 2002 Nov; 277(47):45680-7. PubMed ID: 12244095
[TBL] [Abstract][Full Text] [Related]
4. A pyrrolo-pyrimidine derivative targets human primary AML stem cells in vivo.
Saito Y; Yuki H; Kuratani M; Hashizume Y; Takagi S; Honma T; Tanaka A; Shirouzu M; Mikuni J; Handa N; Ogahara I; Sone A; Najima Y; Tomabechi Y; Wakiyama M; Uchida N; Tomizawa-Murasawa M; Kaneko A; Tanaka S; Suzuki N; Kajita H; Aoki Y; Ohara O; Shultz LD; Fukami T; Goto T; Taniguchi S; Yokoyama S; Ishikawa F
Sci Transl Med; 2013 Apr; 5(181):181ra52. PubMed ID: 23596204
[TBL] [Abstract][Full Text] [Related]
5. Suppression of autophagy and HCK signaling promotes PTGS2
Mei J; Zhou WJ; Zhu XY; Lu H; Wu K; Yang HL; Fu Q; Wei CY; Chang KK; Jin LP; Wang J; Wang YM; Li DJ; Li MQ
Autophagy; 2018; 14(8):1376-1397. PubMed ID: 29962266
[TBL] [Abstract][Full Text] [Related]
6. The inhibition of SRC family kinase suppresses pancreatic cancer cell proliferation, migration, and invasion.
Je DW; O YM; Ji YG; Cho Y; Lee DH
Pancreas; 2014 Jul; 43(5):768-76. PubMed ID: 24763074
[TBL] [Abstract][Full Text] [Related]
7. Activity cliff for 7-substituted pyrrolo-pyrimidine inhibitors of HCK explained in terms of predicted basicity of the amine nitrogen.
Yuki H; Kikuzato K; Koda Y; Mikuni J; Tomabechi Y; Kukimoto-Niino M; Tanaka A; Shirai F; Shirouzu M; Koyama H; Honma T
Bioorg Med Chem; 2017 Aug; 25(16):4259-4264. PubMed ID: 28662963
[TBL] [Abstract][Full Text] [Related]
8. The Src tyrosine kinase Hck is required for Tel-Abl- but not for Tel-Jak2-induced cell transformation.
Pecquet C; Nyga R; Penard-Lacronique V; Smithgall TE; Murakami H; Régnier A; Lassoued K; Gouilleux F
Oncogene; 2007 Mar; 26(11):1577-85. PubMed ID: 16953222
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic cell kinase (HCK) is a potential therapeutic target for dysplastic and leukemic cells due to integration of erythropoietin/PI3K pathway and regulation of erythropoiesis: HCK in erythropoietin/PI3K pathway.
Roversi FM; Pericole FV; Machado-Neto JA; da Silva Santos Duarte A; Longhini AL; Corrocher FA; Palodetto B; Ferro KP; Rosa RG; Baratti MO; Verjovski-Almeida S; Traina F; Molinari A; Botta M; Saad ST
Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):450-461. PubMed ID: 27840303
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic cell kinase (HCK) as a therapeutic target in immune and cancer cells.
Poh AR; O'Donoghue RJ; Ernst M
Oncotarget; 2015 Jun; 6(18):15752-71. PubMed ID: 26087188
[TBL] [Abstract][Full Text] [Related]
11. Insights on hematopoietic cell kinase: An oncogenic player in human cancer.
Luo S; Du S; Tao M; Cao J; Cheng P
Biomed Pharmacother; 2023 Apr; 160():114339. PubMed ID: 36736283
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of IL-6-dependent growth of myeloma cells by an acidic peptide repressing the gp130-mediated activation of Src family kinases.
Hausherr A; Tavares R; Schäffer M; Obermeier A; Miksch C; Mitina O; Ellwart J; Hallek M; Krause G
Oncogene; 2007 Jul; 26(34):4987-98. PubMed ID: 17310994
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic inhibition of Jak activity inhibits progression of gastrointestinal tumors in mice.
Stuart E; Buchert M; Putoczki T; Thiem S; Farid R; Elzer J; Huszar D; Waring PM; Phesse TJ; Ernst M
Mol Cancer Ther; 2014 Feb; 13(2):468-74. PubMed ID: 24398427
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of granulocyte-macrophage colony-stimulating factor signaling and microglial proliferation by anti-CD45RO: role of Hck tyrosine kinase and phosphatidylinositol 3-kinase/Akt.
Suh HS; Kim MO; Lee SC
J Immunol; 2005 Mar; 174(5):2712-9. PubMed ID: 15728479
[TBL] [Abstract][Full Text] [Related]
15. Identification of pyrrolo[2,3-d]pyrimidines as potent HCK and FLT3-ITD dual inhibitors.
Koda Y; Kikuzato K; Mikuni J; Tanaka A; Yuki H; Honma T; Tomabechi Y; Kukimoto-Niino M; Shirouzu M; Shirai F; Koyama H
Bioorg Med Chem Lett; 2017 Nov; 27(22):4994-4998. PubMed ID: 29037944
[TBL] [Abstract][Full Text] [Related]
16. Regulation of p73 by Hck through kinase-dependent and independent mechanisms.
Paliwal P; Radha V; Swarup G
BMC Mol Biol; 2007 May; 8():45. PubMed ID: 17535448
[TBL] [Abstract][Full Text] [Related]
17. Dys-regulated activation of a Src tyroine kinase Hck at the Golgi disturbs N-glycosylation of a cytokine receptor Fms.
Hassan R; Suzu S; Hiyoshi M; Takahashi-Makise N; Ueno T; Agatsuma T; Akari H; Komano J; Takebe Y; Motoyoshi K; Okada S
J Cell Physiol; 2009 Nov; 221(2):458-68. PubMed ID: 19585521
[TBL] [Abstract][Full Text] [Related]
18. The proto-oncogene p120(Cbl) is a downstream substrate of the Hck protein-tyrosine kinase.
Howlett CJ; Bisson SA; Resek ME; Tigley AW; Robbins SM
Biochem Biophys Res Commun; 1999 Apr; 257(1):129-38. PubMed ID: 10092522
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial ROS accumulation inhibiting JAK2/STAT3 pathway is a critical modulator of CYT997-induced autophagy and apoptosis in gastric cancer.
Cao Y; Wang J; Tian H; Fu GH
J Exp Clin Cancer Res; 2020 Jun; 39(1):119. PubMed ID: 32576206
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of hematopoietic cell kinase dysregulates microglial function and accelerates early stage Alzheimer's disease-like neuropathology.
Lim SL; Tran DN; Zumkehr J; Chen C; Ghiaar S; Kieu Z; Villanueva E; Gallup V; Rodriguez-Ortiz CJ; Kitazawa M
Glia; 2018 Dec; 66(12):2700-2718. PubMed ID: 30277607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
